Oct 2026· Journal of Structural Biology· Vol 218, pp.
108384
· 0 citations· 32 references
Medicine
TL;DR
This work provides a mechanistic framework for understanding genotype-phenotype relationships in PMPCA-associated disease and demonstrates that PMPCA mutations impair MPP function through diverse mechanisms involving protein stability, dimerization, substrate selectivity, and allosteric conformational dynamics.
Abstract
The mitochondrial processing peptidase (MPP) is an essential heterodimeric protease responsible for cleavage of N-terminal mitochondrial targeting sequences (N-MTSs) from most nuclear-encoded mitochondrial proteins following import into the mitochondrial matrix. Pathogenic variants in the α-subunit of MPP (PMPCA) cause a spectrum of mitochondrial disorders, including spinocerebellar ataxia type 2 (SCAR2), encephalopathy, and severe neurodevelopmental disease; however, the molecular mechanisms underlying these phenotypes remain poorly understood. Here, we combined biochemical and structural approaches to characterize five disease-associated PMPCA variants (S96L, R185W, R268W, A377T, and G515R). Enzymatic analyses revealed variant-specific defects in substrate processing, with most mutations severely impairing cleavage of the rapidly processed substrate malate dehydrogenase 2. In contrast, several variants exhibited only modest impairment in the processing of the slowly cleaved substrate PINK1. Mass photometry demonstrated reduced heterodimerization of all variants, whereas circular dichroism identified varying degrees of structural destabilization, particularly for S96L and G515R. To define the structural basis of these defects, hydrogen-deuterium exchange mass spectrometry was performed on wild type MPP and selected variants. Pathogenic mutations altered substrate-induced conformational changes within previously characterized substrate-recognition elements, including the glycine-rich loop. Furthermore, we identified a previously unrecognized region, termed the INS loop, that exhibited substrate-dependent protection uniquely in the wild type enzyme but was consistently disrupted across pathogenic variants. Together, these findings demonstrate that PMPCA mutations impair MPP function through diverse mechanisms involving protein stability, dimerization, substrate selectivity, and allosteric conformational dynamics. Our work provides a mechanistic framework for understanding genotype-phenotype relationships in PMPCA-associated disease.
Pathogenic variants in MT-RNR1 are classically associated with aminoglycoside-induced sensorineural hearing loss through disruption of the mitochondrial 12S rRNA decoding center. Their contribution to pediatric neurological disease remains poorly defined. We identified a novel homoplasmic MT-RNR1 variant, m.1014A>G, in...
Irene Marrone, Blendi Ura, F. Celsi et al.· International Journal of Mol...· 0 citations
Mitochondrial disease arises from variants in either the mitochondrial or nuclear genome that impair mitochondrial oxidative phosphorylation. Complex III (ubiquinol:cytochrome c oxidoreductase, CIII2) is a key enzyme of the mitochondrial respiratory chain, catalyzing electron transfer from reduced coenzyme Q10 (ubiquin...
R. W. Taylor, S. Smith, S. Saadi et al.· medRxiv· 0 citations
These findings support a model in which the NTE and CTE act as intramolecular determinants of PINK1 kinase stability and suggest that vertebrate PINK1 has evolved an increased dependence on the mitochondrial import machinery to maintain a functional state.
Tara Shomali, S. Veyron, J. Trempe· bioRxiv· 0 citations
Pathogenic variants in the mitochondrial protein Mitofusin 2 have long been recognized to cause the peripheral neuropathy Charcot-Marie-Tooth Type 2A (CMT2A). However, a small subset of MFN2 variants also impact the central nervous system and cause cerebellar ataxia. The reason for this discrepancy and the mechanisms u...
M. Zaman, A. Mohan, C. Chute et al.· medRxiv· 0 citations
POLGA, the catalytic subunit of the mitochondrial DNA polymerase, is essential for mitochondrial DNA (mtDNA) replication and maintenance. Mutations in POLGA cause progressive external ophthalmoplegia (PEO), but the underlying pathogenic mechanisms remain unclear. Here, we show that the mitochondrial E3 ligase MITOL hyp...
Mutations in the GDAP1 gene, which encodes the ganglioside-induced differentiation-associated protein 1 (GDAP1)—a member of the detoxifying glutathione S-transferase (GST) superfamily—cause Charcot–Marie–Tooth disease (CMT) a genetically heterogeneous group of inherited neuropathies. This mini review correlates the cli...
V. Bunik, A. Emelyanova· Frontiers in Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.